|
Clinical-pathological data
|
MCT1 (PM)
|
MCT1 (nucleus)
|
MCT4 (PM)
|
|---|
|
n
|
Positive (%)
|
p
|
Positive (%)
|
p
|
Positive (%)
|
p
|
|---|
|
Age
| | |
0.153
| |
0.076
| |
0.403
|
|
>51
|
48
|
32 (66.7)
| |
12 (25.0)
| |
29 (60.4)
| |
|
≤51
|
37
|
19 (51.4)
| |
16 (43.2)
| |
19 (51.4)
| |
|
Gender
| | |
0.716
| |
0.174
| |
0.463
|
|
Female
|
33
|
19 (57.6)
| |
8 (24.2)
| |
17 (51.5)
| |
|
Male
|
52
|
32 (61.5)
| |
20 (38.5)
| |
31 (59.6)
| |
|
Race
| | |
0.686
| |
0.896
| |
0.832
|
|
Caucasian
|
63
|
37 (58.7)
| |
21 (33.3)
| |
36 (57.1)
| |
|
Not Caucasian
|
22
|
14 (63.6)
| |
7 (31.8)
| |
12 (54.5)
| |
|
Local
| | |
0.586
| |
0.439
| |
0.154
|
|
Lower extremities
|
63
|
37 (58.7)
| |
22 (34.9)
| |
33 (52.4)
| |
|
Upper extremities
|
23
|
15 (65.2)
| |
6 (26.1)
| |
16 (69.6)
| |
|
Cell lineage
| | |
0.066
| |
<0.001
| |
<0.001
|
|
Fibroblastic/myofibroblastic
|
28
|
16 (57.1)
| |
9 (32.1)
| |
16 (57.1)
| |
|
Smooth muscle
|
17
|
12 (70.6)
| |
3 (17.6)
| |
13 (76.5)
| |
|
Lipogenic
|
17
|
6 (35.3)
| |
13 (76.5)
| |
2 (11.8)
| |
|
Peripheral nerve
|
7
|
4 (57.1)
| |
2 (28.6)
| |
4 (57.1)
| |
|
Miscellaneous
|
17
|
14 (82.4)
| |
1 (5.9)
| |
14 (82.4)
| |
|
Cellular pleomorphism
| | |
0.034
| |
0.010
| |
0.009
|
|
Absence of pleomorphic cells
|
54
|
28 (51.9)
| |
23 (42.6)
| |
25 (46.3)
| |
|
Presence of pleomorphic cells
|
32
|
24 (75.0)
| |
5 (15.6)
| |
24 (75.0)
| |
|
Grade
| | |
<0.001
| |
<0.001
| |
0.011
|
|
Low grade (I)
|
19
|
4 (21.1)
| |
14 (73.7)
| |
6 (31.6)
| |
|
High grade (II e III)
|
67
|
48 (71.6)
| |
14 (20.9)
| |
43 (64.2)
| |
|
Disease progression
| | |
0.018
| |
0.865
| |
0.060
|
|
No
|
25
|
10 (40.0)
| |
8 (32.0)
| |
10 (40.0)
| |
|
Yes
|
56
|
39 (67.2)
| |
20 (33.9)
| |
35 (62.5)
| |
|
Disease recurrence
| | |
0.847
| |
0.640
| |
0.204
|
|
Absent
|
48
|
29 (60.4)
| |
15 (31.2)
| |
24 (50.0)
| |
|
Present
|
36
|
21 (58.3)
| |
13 (36.1)
| |
23 (63.9)
| |
|
Metastasis
| | |
0.156
| |
0.122
| |
0.249
|
|
Absent
|
44
|
23 (52.3)
| |
18 (40.9)
| |
22 (50.0)
| |
|
Present
|
40
|
27 (67.5)
| |
10 (25.0)
| |
25 (62.5)
| |
-
PM- Plasma membrane.
- Significant values are shown in bold.
